Original Research

Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28

Tian C, Ying HF, Zhuang RY, Zhang XW, Lu HM, Wang H, Wang SW, Li Q, Wang CG, Cai X

Cancer Management and Research 2018, 10:6217-6226

Published Date: 22 November 2018